Search the web
Welcome, Guest
[Sign Out, My Account]
Morningstar_Inc.

Tuesday, July 7 2015 9:43am ET - U.S. Markets close in 6 hours and 17 minutes.
Industry Center - Drug Manufacturers - Other
Industry Center > Drug Manufacturers - Other
More On This Industry
Summary
·News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Related Products
· Drugs - Generic
Top Industries
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Diversified Utilities
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
·Tobacco Products, Other
Complete Industry List...
Morningstar Inc.
In-depth Company Dossier Reports on over 7,500 publicly traded U.S. companies. Click here for your free report.
  
Industry Market Summary
Drug Manufacturers - Other
Composite Value: 721.1
Today's Change: -0.46%
S&P 500: -0.21%
chart for
[Drug Manufacturers - Other (^YHOh784)]
Drug Manufacturers - Other News
Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome
Mon 7:00 am ET (PR Newswire)
BOSTON, July 6, 2015 /PRNewswire/ -- Akcea Therapeutics, a wholly-owned subsidiary of Isis Pharmaceuticals, Inc. (NASDAQ: ISIS), announced today that the U.S. Food and Drug Administration has granted Orphan ...
Dr. Reddy’s Unveils New Corporate Brand Identity - (Business Wire)
Status regarding Novo Nordisk's holding of its own shares (30 June 2015) - (Thomson Reuters ONE)
More News on Drug Manufacturers - Other: Latest News,
Industry Top Performers
Intraday Price Performance% ChangeMarket Cap
More Top Intraday Price Performers...
Market Capitalization% ChangeMarket Cap
Novo Nordisk A/S Common Stock [NVO] 0.00% $145.3 B
Teva Pharmaceutical Industries [TEVA] 0.00% $50.0 B
Endo International plc [ENDP] 0.00% $14.4 B
Dr. Reddy's Laboratories Ltd Co [RDY] 0.00% $9.4 B
United Therapeutics Corporation [UTHR] 0.00% $8.1 B
More Top Companies by Market Cap...
More Top Performers: by Valuation, by Growth, by Financial Strength
Industry Calendar
Recent Events
Date Co Event
06/29/15 PTX Pernix Therapeutics Holdings, I coverage initiated by Brean Capital
06/11/15 DEPO Depomed, Inc. coverage initiated by Morgan Stanley
06/09/15 NVO Novo Nordisk A/S Common Stock upgraded by Morgan Stanley
More Recent Events...
Sponsor Results
Hot New Stock - OMVS
OMVS Expands Upcoming On-Demand Trucking App. Invest Today!
onthemovesystems.com
B2B Email & Mailing Lists
Quality Industry Lists. Real-Time Vetting. 95% Deliverability.
prospect-cloud.com/industry-lists
In-Person Training Course
Global Regulatory Strategy. Asia-Pacific and Emerging Markets
www.DIAHome.org/OnlineTraining
(What's This?)
  
Locate Industry by Company
Enter Symbol:
Industry Statistics
Market Capitalization:246B
Price / Earnings:28.4
Price / Book:31.3
Net Profit Margin (mrq):18.4%
Price To Free Cash Flow (mrq):-4942.1
Return on Equity:20.8%
Total Debt / Equity:27.6
Dividend Yield:1.5%
View Industry Browser
Community Spotlight
Most Active Boards
Board Popularity
DEPO
PCYC
TPPH
Unusually Active Boards
Board Variance
PCYC
ADLR
ARQL

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Manufacturers - Other Headlines
More Finance RSS Feeds


Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2015 Morningstar, Inc. All Rights Reserved. Company information © 2015 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?